MD Medical Group Announces Openning of Lapino Hospital - News — Group of companies "Mother and child"


MD Medical Group Investments Plc (“MD Medical Group” or the “Company” – LSE: MDMG), Russia’s leading provider of private women’s and children’s healthcare, announces today that it has received the licence required to operate its new state-of-the-art Lapino hospital in the Moscow Region, and will be ready to receive its first patients as of Monday, 26 November 2012.

Commenting on the opening of the Lapino hospital,
Chairman of MD Medical Group, Dr Mark Kurtser said:

“The day when Lapino would open its doors to its first patients is the day we have all been waiting for. I have long wanted to create a new medical centre where patients would be treated in the most comfortable and friendly environment; where women could deliver in the best conditions; and where doctors could work with the most sophisticated equipment. I am proud of the fact that we continue to be the only company in Russia to have succeeded in building and operating purpose-built, modern medical centres. Lapino is our second such hospital, representing a US$ 150 million investment, and we are happy that it is opening on schedule.”

Chief Executive Officer of MD Medical Group,
Dr Elena Mladova added:

“We continue to see strong demand for high-quality medical services in Russia, and particularly note the year-on-year growth in the number of deliveries in Moscow and the Moscow region. These trends create a very favourable operating environment for our company. The number of deliveries at our existing clinic has reached 2,900 year-to-date, already more than for the full-year 2011, and we are operating at full capacity.

“The new state-of-the-art, 182-bed medical centre is located in an affluent Moscow suburban area and, in addition to maternity care and paediatrics, will focus on diagnostics, trauma, therapy and rehabilitation. The annual capacity of the new hospital will be 400,000 outpatient visits and 3,000 deliveries. Our medical personnel are fully prepared to accept their first patients in Lapino, while management is focused on ensuring the dynamic ramp up of the clinic.”

The ceremonial opening of the new hospital took place on Saturday, 24 November 2012. Among those who came to congratulate the Company were Olga Golodets, Deputy Prime Minister of Russia, Andrey Vorobyev, Acting Governor of the Moscow region, Andrey Kostin, Chairman of VTB, and Kirill Dmitriev, CEO of the Russian Direct Investment Fund.


Learn more about MD Medical Group. Visit the Company’s web site at

For further information please contact:

MD Medical Group
Anastasia Anichenkova
Tel: +7 495 332 6670 / +7 916 661 6242
Andrey Braginskiy
Tel: +7 985 211 7478
Tom Blackwell / Anna Yarmarkova — Moscow
Tel: +7 495 363 2846
Sarah Macleod / Mary-Jane Elliott — London
Tel: +44 20 7920 2300


About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women’s health and paediatrics. The company manages ten modern healthcare facilities, including two hospitals and eight outpatient clinics in Moscow, St. Petersburg, Ufa and Perm. In addition, two franchised outpatient clinics operate in Kyiv and one franchised outpatient clinic in Irkutsk. In 2013, the Company expects to begin construction of its third hospital in Ufa.

The Company’s first hospital, the Perinatal Medical Center (PMC), a 250-bed medical facility opened its doors in 2006. In 2011, there were 2,859 deliveries in PMC. The number of outpatient treatments for 2011 in PMC and the Company’s outpatient clinics totalled 314,098.

As of June 30, 2012, the Company employed approximately 1,461 medical specialists and staff. The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since October 12, 2012.

Forward-Looking Statements

This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken as a repress release that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.

Back to news list